Covance has expanded its central laboratory capabilities with a new biorepository facility on its US campus in Greenfield, India.

The 20,000 sq ft building will be used for the long-term storage of clinical trial specimens, including plasma, serum, whole blood, DNA, PBMC (peripheral blood mononuclear cell) samples and tissue. According to Covance, the biorepository has “unsurpassed” security and safety features, including the ability to withstand wind speeds in excess of 300 miles per hour.

It is also adjacent to the company’s Biomarker Center of Excellence, set up last year, and “in close proximity” to its largest central laboratory location, “allowing clients to protect their specimens and leverage Covance’s biomarker and clinical testing capabilities”.

Through its central laboratory network, the US-based drug development services provider has been storing and managing patient specimens for the past 20 years. The growing number of global clinical trials, as well as regulatory demands around the retesting of specimens, has “driven pharmaceutical and biotech companies to look for a comprehensive provider of long-term storage and future testing services”, Covance says.

“We believe Covance has the latest technology and capacity to meet our clients’ sample storage and testing needs for many years to come,” commented Deborah Tanner, corporate senior vice president and president, Central Laboratory Services and Discovery & Translational Services.

“Our experience in clinical trial specimen testing and storage enables us to manage the entire lifecycle from specimen draw to final destruction, which minimises the risk for our clients due to shipping and moving specimens.”